AI + live data · analyst records & stock signals
KoalCheckKoalCheck
LeaderboardMembershipBuilder
Connect your AI client via MCP
Endpoint (paste into an MCP client — anonymous, free, no key)
https://mcp.koalcheck.com/mcp
Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

CapabilitiesUser guide
← @emmetlsavage

$GH

BULLISH2025-10-29
Price around the call
↑ 2025-10-29
By horizon✓ hit+13.8%
1d
…
5d
✓ +5.6%
21d
✓ +13.8%
Original post
Emmet Savage · 2025-10-29

Guardant Health $GH Q3 earnings: • Revenue up 39% YoY to $265M • Raised 2025 guidance to $965–$970M (+31%) • Oncology tests +40%, Screening revenue up from $1M → $24M! • Gross margin 66% (vs 63%) Shield multi-cancer test launch, FDA submission for Guardant360, & new Quest + ACS partnerships. I mean, come on. That’s pretty good. Shares up 16% after hours as I type.

View on X ↗
KoalCheckKoalCheck

Honest, price-verified track records for US-stock callers on X.

© 2026 KoalCheck. All rights reserved.

ProductLeaderboardCall streamHot tickersAI assistantMembershipBuilderMCP & API access
LegalTerms of ServicePrivacy PolicyDisclaimer
ContactX · @koalcheck[email protected]

KoalCheck is an information-aggregation and research tool — not investment advice. Data may be delayed or inaccurate. Investing involves risk; decide carefully.

Tweet content © its original authors. Data sources: public X content · SEC EDGAR · FINRA. Methodology and site design © KoalCheck.